Frontlight ResearchEarly access
CompletedNo phase
Journey™ UNI Post Market Clinical Follow-Up
Key facts
- Who runs it
- Smith & Nephew, Inc.
- Where
- Nashville, Park Ridge, and Scottsdale, United StatesSee the 3 sitesAlso in 1 other country, 1 site
- Trial code
- Status
- Completed
- People taking part
- 131 people enrolled
- Started
- 11 Apr 2018
- Ended
- 25 Jan 2024
- Type of study
- Observational
- Treatments tested
- Journey UNI Unicompartmental Knee System
- Record updated
- 2 November 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (12)Hide the full registry criteria
Who can take part
- Between 12 and 48 months previously, subject had unicompartmental knee replacement implanted for unicompartmental, NIDJD including OA, traumatic arthritis, avascular necrosis, for correction of functional deformity, or to repair a fracture that was unmanageable using other techniques
- Subject received a JOURNEY UNI UKS implant (consisting of a femoral component, tibial baseplate, and a tibial insert)
- Subject was considered skeletally mature at the time of surgery and was at least 18 years of age
- Subject is willing to have retrospective data collected and to participate in required prospective follow-up visit(s) at the investigational site and to complete study procedures and questionnaires
- Subject has consented to participate in the study by signing the Institutional Review Board (IRB)/Ethics Committee (EC)-approved informed consent form (ICF)
Who cannot take part
- Subject has Body Mass Index (BMI) > 40 within 1 month of surgery
- Subjects who have received the Journey UNI UKS as part of a revision surgery
- Subject is entered in another investigational drug, biologic, or device study or has been treated with an investigational product in the past 30 days
- Subject has a condition that may interfere with the unicompartmental knee arthroplasty (UKA) survival or outcome (e.g. Paget's or Charcot's disease, vascular insufficiency, muscular atrophy, uncontrolled diabetes, moderate to severe renal insufficiency or neuromuscular disease)
- Subject has a known allergy to study device or one or more of its components
- Subject, in the opinion of the Principal Investigator (PI), has an emotional or neurological condition that would preempt his/her ability or willingness to participate in the study including mental illness, mental retardation, drug or alcohol abuse
- Subject is known to be at risk for loss to follow-up, or failure to return for scheduled visits
Where in United States
Also in 1 other country, 1 site
- Tennessee Orthopedic Alliance, P.A.Nashville, United States
- Illinois Bone and Joint InstitutePark Ridge, United States
- Orthopaedic Specialists of Central Arizona-ScottsdaleScottsdale, United States
About the trial
What the trial wants to find out
This is a retrospective/prospective, open-label single cohort, multicenter study to collect relevant clinical data from subjects with unicompartmental degeneration of the knee in whom the Journey UNI UKS was previously implanted.
The group in the trial
- Journey™ UNI Unicompartmental Knee System
Subjects previously received knee replacement
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Follow-Up of Subjects With a Journey™ UNI Unicompartmental Knee System Implant
- Record updated
- 2 November 2026